Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe?

BACKGROUND: Guidelines suggest that patients discontinue Clopidogrel at least 5 days prior to coronary artery bypass grafting (CABG). Those with acute coronary syndrome (ACS) are at high risk for myocardial infarction (MI) if not treated with dual antiplatelet therapy (DAPT). We sought to assess pre...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cardiothorac Surg
Asıl Yazarlar: Charif, Fida, Hamdan, Righab, Youness, Genane, El Zein, Ali, Issa, Mohamad, Jassar, Yehya, Younes, Mahmoud, Saab, Mohamad
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6880414/
https://ncbi.nlm.nih.gov/pubmed/31775803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13019-019-1028-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller